Edition:
United States

People: Synergy Pharmaceuticals Inc (SGYP.O)

SGYP.O on Nasdaq

4.67USD
12:42pm EDT
Change (% chg)

$-0.07 (-1.48%)
Prev Close
$4.74
Open
$4.76
Day's High
$4.84
Day's Low
$4.58
Volume
2,364,228
Avg. Vol
5,805,753
52-wk High
$7.15
52-wk Low
$3.34

Joslyn, Alan 

Dr. Alan F. Joslyn, Ph.D. is Independent Director of the Company. He served as a director of our Company since October 2009. Since April 2014, Dr. Joslyn has been a partner in Lazarus Pharmaceuticals, LLC. From March 2010 to April 2014, Dr. Joslyn was a drug development consultant to Sentinella Pharmaceuticals. From August 2009 to October 2012 Dr. Joslyn served as the Chief Executive Officer of Edusa Pharmaceuticals, a privately held biotechnology company. From March 2007 to March 2009, Dr. Joslyn served as President and Chief Executive Officer of Mt. Cook Pharma and as Senior Vice President of Research & Development at Penwest Pharmaceuticals from 2004 to 2007. From 1995 to 2004, Dr. Joslyn held a number of leadership positions within Johnson & Johnson focusing on development of gastroenterology products including Propulsid®, Motilium®, Aciphex® and prucalopride. Dr. Joslyn received his B.S. in medicinal chemistry, B.A. in biology and Ph.D. in biochemical pharmacology from the State University of New York at Buffalo.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gary Jacob

2,550,180

Gary Gemignani

--

Marino Garcia

--

Patrick Griffin

1,135,330

Troy Hamilton

1,095,180

Bernard Denoyer

595,031
As Of  30 Dec 2016